학술논문

Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo.
Document Type
Article
Source
Cell Discovery; 8/12/2021, Vol. 7 Issue 1, p1-15, 15p
Subject
RECOMBINANT proteins
SARS-CoV-2
TREATMENT effectiveness
BINDING site assay
ANTIVIRAL agents
PREVENTIVE medicine
Language
ISSN
20565968
Abstract
Copyright of Cell Discovery is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)